Literature DB >> 22427096

Treatment of elevated pulmonary artery pressure in a child after Glenn procedure: transcatheter closure of pulmonary artery banding with subsequent sildenafil therapy.

Jose Pascual Salas Llamas1, Małgorzata Szkutnik, Roland Fiszer, Jacek Białkowski.   

Abstract

An additional source of pulmonary blood flow in a patient with bidirectional Glenn procedure (BGD) may cause elevation of mean pulmonary artery pressure (MPAP), precluding safe completion of the Fontan operation. We present a case of single ventricle physiology after pulmonary artery banding (PAB) and Glenn procedure. At the age of six years, cardiac catheterisation revealed in the patient elevated MPAP (22 mm Hg). The PAB was closed through the right internal jugular vein with an Amplatzer Atrial Septal Occluder. After the procedure, MPAP remained at a similar level. Sildenafil oral therapy was applied for six months. Subsequent heart catheterisation confirmed complete closure of PAB and decrease of MPAP to 10 mm Hg. The abovementioned complex treatment of elevated MPAP pressure in a child after Glenn therapy allowed safe completion of the Fontan operation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427096

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  4 in total

Review 1.  Current challenges in pediatric pulmonary hypertension.

Authors:  Shinichi Takatsuki; David Dunbar Ivy
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

2.  Midterm results of sildenafil therapy in two complex patients with elevated pulmonary artery pressure after cavopulmonary connection.

Authors:  Jacek Białkowski; Małgorzata Szkutnik; Roland Fiszer
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

3.  Combined strategy of Waterston shunt percutaneous occlusion and medical treatment with sildenafil for management of pulmonary hypertension in an adult patient with corrected tetralogy of Fallot.

Authors:  Giancarla Scalone; Omar Gomez-Monterrosas; Roland Fiszer; Małgorzata Szkutnik; Michał Gałeczka; Jacek Białkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-09-25       Impact factor: 1.426

4.  Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV-INHIBITION study design.

Authors:  Pascal Amedro; Arthur Gavotto; Hamouda Abassi; Marie-Christine Picot; Stefan Matecki; Sophie Malekzadeh-Milani; Marilyne Levy; Magalie Ladouceur; Caroline Ovaert; Philippe Aldebert; Jean-Benoit Thambo; Alain Fraisse; Marc Humbert; Sarah Cohen; Alban-Elouen Baruteau; Clement Karsenty; Damien Bonnet; Sebastien Hascoet
Journal:  ESC Heart Fail       Date:  2020-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.